Literature DB >> 4561148

Treatment of ovarian carcinoma: possibilities for progress.

C M Bagley, R C Young, G P Canellos, V T DeVita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4561148     DOI： 10.1056/NEJM197210262871705

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  High volume intraperitoneal chemotherapy ("belly bath") for ovarian cancer. Pharmacologic basis and early results.

Authors:  R B Jones; C E Myers; A M Guarino; R L Dedrick; S M Hubbard; V T DeVita
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

2.  President's address. Cancer and the ovary.

Authors:  R Percival
Journal:  Proc R Soc Med       Date:  1974-05

3.  Radiation therapy in the treatment of patients with cancer of the ovary.

Authors:  R S Bush
Journal:  Bull N Y Acad Med       Date:  1983-10

4.  The staging and treatment of epithelial ovarian cancer.

Authors:  R C Young; R I Fisher
Journal:  Can Med Assoc J       Date:  1978-08-12       Impact factor: 8.262

5.  Chemotherapy of ovarian cancer directed by the human tumor stem cell assay.

Authors:  D S Alberts; H S Chen; S E Salmon; E A Surwit; L Young; T E Moon; F L Meyskens
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  High-dose 5-fluorouracil and leucovorin as second-line chemotherapy in patients with platinum-resistant epithelial ovarian cancer.

Authors:  J T Kamphuis; M C Huider; G J Ras; C A Verhagen; I Kateman; J H Vreeswijk; J T Burghouts
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene.

Authors:  Caitlin T Fierheller; Laure Guitton-Sert; Wejdan M Alenezi; Timothée Revil; Kathleen K Oros; Yuandi Gao; Karine Bedard; Suzanna L Arcand; Corinne Serruya; Supriya Behl; Liliane Meunier; Hubert Fleury; Eleanor Fewings; Deepak N Subramanian; Javad Nadaf; Jeffrey P Bruce; Rachel Bell; Diane Provencher; William D Foulkes; Zaki El Haffaf; Anne-Marie Mes-Masson; Jacek Majewski; Trevor J Pugh; Marc Tischkowitz; Paul A James; Ian G Campbell; Celia M T Greenwood; Jiannis Ragoussis; Jean-Yves Masson; Patricia N Tonin
Journal:  Genome Med       Date:  2021-12-03       Impact factor: 11.117

8.  Clinical correlates of in vitro drug sensitivities of ovarian cancer cells.

Authors:  L Morasca; E Erba; M Vaghi; C Ghelardoni; C Mangioni; C Sessa; F Landoni; S Garattini
Journal:  Br J Cancer       Date:  1983-07       Impact factor: 7.640

Review 9.  Achievements of cancer chemotherapy.

Authors:  J S Tobias; J M Whitehouse
Journal:  J R Coll Physicians Lond       Date:  1976-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.